Merit Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.32M | Buy |
47,951
+18,722
| +64% | +$2.08M | 0.06% | 262 |
|
|
2025
Q1 | $3.28M | Buy |
29,229
+9,522
| +48% | +$1.07M | 0.05% | 297 |
|
|
2024
Q4 | $1.82M | Buy |
19,707
+5,635
| +40% | +$520K | 0.03% | 371 |
|
|
2024
Q3 | $1.18M | Sell |
14,072
-1,844
| -12% | -$155K | 0.03% | 381 |
|
|
2024
Q2 | $1.09M | Sell |
15,916
-2,885
| -15% | -$198K | 0.02% | 384 |
|
|
2024
Q1 | $1.22M | Buy |
18,801
+6,523
| +53% | +$423K | 0.03% | 351 |
|
|
2023
Q4 | $995K | Sell |
12,278
-6,994
| -36% | -$567K | 0.03% | 318 |
|
|
2023
Q3 | $1.44M | Sell |
19,272
-79
| -0.4% | -$5.92K | 0.05% | 266 |
|
|
2023
Q2 | $1.49M | Buy |
19,351
+5,290
| +38% | +$408K | 0.05% | 263 |
|
|
2023
Q1 | $1.17M | Buy |
14,061
+2,086
| +17% | +$173K | 0.04% | 264 |
|
|
2022
Q4 | $1.03M | Buy |
11,975
+3,114
| +35% | +$267K | 0.04% | 291 |
|
|
2022
Q3 | $547K | Sell |
8,861
-6,408
| -42% | -$396K | 0.02% | 341 |
|
|
2022
Q2 | $944K | Buy |
+15,269
| New | +$944K | 0.03% | 263 |
|